Referral of patients with kidney impairment for specialist care in developing country of sub-saharan Africa

Renal Failure

Volumn 31, Issue 5, 2009, Pages 341-348

  Halle, Marie P E ^a   Kengne, Andre P ^b   Ashuntantang, Gloria ^c  

^a DOUALA GENERAL HOSPITAL   (Cameroon)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF YAOUNDÉ I   (Cameroon)

Author keywords

Africa south of the Sahara; Cameroon; Dialysis; Kidney diseases; Kidney failure; Referral

Indexed keywords

ALBUMIN; CALCIUM; CHLORIDE; CHOLESTEROL; CREATININE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHORUS; POTASSIUM; SODIUM; TRIACYLGLYCEROL; UREA; URIC ACID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGE DISTRIBUTION; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; CALCIUM BLOOD LEVEL; CAMEROON; CHLORIDE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CHRONIC GLOMERULONEPHRITIS; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; COMORBIDITY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DEVELOPING COUNTRY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; GENERAL PRACTITIONER; GLOMERULUS FILTRATION RATE; GOUT; HEALTH CARE PERSONNEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDICAL SPECIALIST; OUTPATIENT DEPARTMENT; PATIENT REFERRAL; PHOSPHATE BLOOD LEVEL; PHYSICIAN; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; SEX DIFFERENCE; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL; URINARY TRACT DISEASE;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; AGE FACTORS; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; FEMALE; HUMANS; INCIDENCE; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MIDDLE AGED; NEPHROLOGY; ODDS RATIO; PROBABILITY; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SOCIOECONOMIC FACTORS; SPECIALIZATION; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 70849109297     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220902882014     Document Type: Article

References (23)

1. Thorp ML, Eastman L, Smith DH, Johnson ES. Managing the burden of chronic kidney disease. Dis Manag. 2006;9:115-121.
2. U.S. Renal Data System. USRDS 2002 annual data report: Atlas of end-stage renal disease in the United States. Bethesda, Md.: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2002.
3. Lameire N, Wauters JP, Teruel JL, Van Biesen W, Vanholder R. An update on the referral pattern of patients with end-stage renal disease. Kidney Int Suppl. 2002:27-34.
4. Jungers P, Joly D, Nguyen-Khoa T, Mothu N, Bassilios N, Grunfeld JP. [Continued late referral of patients with chronic kidney disease. Causes, consequences, and approaches to improvement]. Presse Med. 2006;35:17-22.
5. Schmidt RJ, Domico JR, Sorkin MI, Hobbs G. Early referral and its impact on emergent first dialyses, health care costs, and outcome. Am J Kidney Dis. 1998;32:278-283.
6. National Kidney Fondation/ Kidney Disease Outcome Quality Initiative. Clinical practices guidelines for chronic kidney disease: Evaluation, stratification and classification. Am J Kidney Dis. 2002;39 (Suppl. 1):S1-S256.
7. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
8. Lhotta K, Zoebl M, Mayer G, Kronenberg F. Late referral defined by renal function: Association with morbidity and mortality. J Nephrol. 2003;16:855-861.
9. Roderick P, Jones C, Drey N, et al. Late referral for endstage renal disease: A region-wide survey in the south west of England. Nephrol Dial Transplant. 2002;17:1252-1259.
10. Arora P, Obrador GT, Ruthazer R, et al. Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center. J Am Soc Nephrol. 1999;10:1281-1286.
11. Iseki K, Tozawa M, Iseki C, Takishita S, Ogawa Y. Demographic trends in the Okinawa Dialysis Study (OKIDS) registry (1971-2000). Kidney Int. 2002;61:668-675.
12. Lameire N, Van Biesen W. The pattern of referral of patients with end-stage renal disease to the nephrologists-a European survey. Nephrol Dial Transplant. 1999;14 (Suppl. 6):16-23. (Pubitemid 29462210)
13. Choukem SP, Kengne AP, Dehayem YM, Simo NL, Mbanya JC. Hypertension in people with diabetes in sub-Saharan Africa: Revealing the hidden face of the iceberg. Diabetes Res Clin Pract. 2007;77:293-299.
14. Kamadjeu RM, Edwards R, Atanga JS, Unwin N, Kiawi EC, Mbanya JC. Prevalence, awareness and management of hypertension in Cameroon: Findings of the 2003 Cameroon Burden of Diabetes Baseline Survey. J Hum Hypertens. 2006;20:91-92.
15. Mbanya JC, Kengne AP, Assah F. Diabetes care in Africa. Lancet. 2006;368:1628-1629.
16. Obialo CI, Ofili EO, Quarshie A, Martin PC. Ultralate referral and presentation for renal replacement therapy: Socioeconomic implications. Am J Kidney Dis. 2005;46:881-886.
17. Kessler M, Frimat L, Panescu V, Briancon S. Impact of nephrology referral on early and midterm outcomes in ESRD: Epidemiologie de l'insuffisance renale chronique terminale en Lorraine (EPIREL): Results of a two-year, prospective, community-based study. Am J Kidney Dis. 2003; 42:474-485.
18. St Peter WL, Schoolwerth AC, McGowan T, McClellan WM. Chronic kidney disease: Issues and establishing programs and clinics for improved patient outcomes. Am J Kidney Dis. 2003;41:903-924.
19. Stack AG. Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United States. Am J Kidney Dis. 2003;41:310-318.
20. Levin A. Consequences of late referral on patient outcomes. Nephrol Dial Transplant. 2000;15 (Suppl. 3):8-13.
21. Nelson AW, Mackinnon B, Traynor J, Geddes CC. The relationship between serum creatinine and estimated glomerular filtration rate: Implications for clinical practice. Scott Med J. 2006;51:5-9.
22. Zahran A, El-Husseini A, Shoker A. Can cystatin C replace creatinine to estimate glomerular filtration rate? A literature review. Am J Nephrol. 2007;27:197-205.
23. Van Biesen W, Vanholder R, Veys N, et al. The importance of standardization of creatinine in the implementation of guidelines and recommendations for CKD: Implications for CKD management programmes. Nephrol Dial Transplant. 2006;21:77-83.